Through a combination of bioinformatics prediction and in vitro experimental validation, we investigated the potential role of TRIM6 in the pathogenesis and prognosis of AML, with the goal of providing new insights into molecular biomarkers for this disease. Here, TRIM6 is linked to acute myeloid leukemia.